Cargando…
Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
Bypassing the blood–brain barrier is one of the primary considerations when designing compounds intended to function in the central nervous system (CNS). Intranasal (IN) administration of otherwise blood–brain barrier impermeable molecules can result in high CNS concentrations and low systemic accum...
Autores principales: | McGowan, Jeremy WD, Shao, Qingmei, Vig, Parminder JS, Bidwell, Gene L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019317/ https://www.ncbi.nlm.nih.gov/pubmed/27660412 http://dx.doi.org/10.2147/DDDT.S106216 |
Ejemplares similares
-
Elastin-like polypeptide delivery of anti-inflammatory peptides to the brain following ischemic stroke
por: Howell, John Aaron, et al.
Publicado: (2023) -
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
por: Kuna, Marija, et al.
Publicado: (2018) -
Intranasal Administration for Pain: Oxytocin and Other Polypeptides
por: Bharadwaj, Vimala N., et al.
Publicado: (2021) -
Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma
por: Dragojevic, Sonja, et al.
Publicado: (2019) -
Development of elastin-like polypeptide for targeted specific gene delivery in vivo
por: Yi, Aena, et al.
Publicado: (2020)